{"id":9173,"date":"2025-01-21T12:14:58","date_gmt":"2025-01-21T17:14:58","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&#038;p=9173"},"modified":"2025-06-26T15:17:26","modified_gmt":"2025-06-26T20:17:26","slug":"observatorio-de-buenas-practicas-regulatorias","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/en\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/","title":{"rendered":"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)"},"content":{"rendered":"<p>Este informe es un an\u00e1lisis independiente sobre la adopci\u00f3n de las Buenas Pr\u00e1cticas Regulatorias (BPR) en la regulaci\u00f3n de productos farmac\u00e9uticos en ocho (8) pa\u00edses de Am\u00e9rica Latina.<br>La informaci\u00f3n proviene de fuentes confiables, sin embargo, los datos e informaci\u00f3n aqu\u00ed descrita estar\u00e1n sujetos a ser actualizados y validados. Este estudio no es una evaluaci\u00f3n del nivel de madurez de las autoridades regulatorias nacionales de medicamentos, ni sustituye o reemplaza las evaluaciones oficiales realizadas por organismos autorizados como la Organizaci\u00f3n Mundial de la Salud (OMS) o la Organizaci\u00f3n Panamericana de la Salud (OPS).<\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2025\/01\/Observatorio-de-Buenas-Praicticas-Regulatorias.-.pdf\" target=\"_blank\">Preview<\/a><\/p>\n\n\n\n<p><\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div>","protected":false},"author":24,"parent":0,"template":"","ano":[88],"idioma":[31],"etiquetas-publicacion":[],"categoria-publicacion":[],"class_list":["post-9173","publicaciones","type-publicaciones","status-publish","hentry","ano-88","idioma-espanol"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP) - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/en\/publications\/observatorio-de-buenas-practicas-regulatorias\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)\" \/>\n<meta property=\"og:description\" content=\"Este informe es un an\u00e1lisis independiente sobre la adopci\u00f3n de las Buenas Pr\u00e1cticas Regulatorias (BPR) en la regulaci\u00f3n de productos farmac\u00e9uticos en ocho (8) pa\u00edses de Am\u00e9rica Latina.La informaci\u00f3n proviene de fuentes confiables, sin embargo, los datos e informaci\u00f3n aqu\u00ed descrita estar\u00e1n sujetos a ser actualizados y validados. Este estudio no es una evaluaci\u00f3n del [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/en\/publications\/observatorio-de-buenas-practicas-regulatorias\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-26T20:17:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/observatorio-de-buenas-practicas-regulatorias\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/observatorio-de-buenas-practicas-regulatorias\\\/\",\"name\":\"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP) - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2025-01-21T17:14:58+00:00\",\"dateModified\":\"2025-06-26T20:17:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/observatorio-de-buenas-practicas-regulatorias\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/observatorio-de-buenas-practicas-regulatorias\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/observatorio-de-buenas-practicas-regulatorias\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP) - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/en\/publications\/observatorio-de-buenas-practicas-regulatorias\/","og_locale":"en_US","og_type":"article","og_title":"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)","og_description":"Este informe es un an\u00e1lisis independiente sobre la adopci\u00f3n de las Buenas Pr\u00e1cticas Regulatorias (BPR) en la regulaci\u00f3n de productos farmac\u00e9uticos en ocho (8) pa\u00edses de Am\u00e9rica Latina.La informaci\u00f3n proviene de fuentes confiables, sin embargo, los datos e informaci\u00f3n aqu\u00ed descrita estar\u00e1n sujetos a ser actualizados y validados. Este estudio no es una evaluaci\u00f3n del [&hellip;]","og_url":"https:\/\/fifarma.org\/en\/publications\/observatorio-de-buenas-practicas-regulatorias\/","og_site_name":"FIFARMA","article_modified_time":"2025-06-26T20:17:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/","url":"https:\/\/fifarma.org\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/","name":"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP) - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2025-01-21T17:14:58+00:00","dateModified":"2025-06-26T20:17:26+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Latin American Federation of the Pharmaceutical Industry","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/publicaciones\/9173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/media?parent=9173"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/ano?post=9173"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/idioma?post=9173"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/etiquetas-publicacion?post=9173"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/categoria-publicacion?post=9173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}